Comments to FDA: Probiotics Labeling Share page: Docket Number: FDA-2011-D-0376 Herein CHPA provides feedback on FDA’s recent draft guidance document addressing the labeling of dietary supplements containing live microbials (also referred to as probiotics). Download Document Issues: Dietary Supplements Probiotics Other Issues Labeling Related Posts Press Releases and Statements CHPA Responds to FDA Draft Guidance on NDIN Master Files for Dietary Supplements Apr 3, 2024 Comments Comments Regarding Conducting Remote Regulatory Assessments Questions and Answers, Draft Guidance for Industry Mar 26, 2024 Press Releases and Statements CHPA Responds to Durbin Letter Calling for DSHEA Modernization Mar 18, 2024